These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 22282903)
1. Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine. Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E J Psychopharmacol; 1989 Jan; 3(3):180-5. PubMed ID: 22282903 [TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen. Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E J Psychopharmacol; 1990 Jan; 4(4):204-9. PubMed ID: 22281849 [TBL] [Abstract][Full Text] [Related]
3. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP). Bianchi G; Caccia S; Della Vedova F; Garattini S Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in rats. Amano M; Goto A; Sakai A; Achiha M; nee Hara ; Takahashi N; Hara C; Ogawa N Jpn J Pharmacol; 1993 Apr; 61(4):311-7. PubMed ID: 8100593 [TBL] [Abstract][Full Text] [Related]
5. Buspirone, gepirone and ipsapirone disrupt both active and passive avoidance responding in rats. Sanger DJ; Joly D; LePichon M Behav Pharmacol; 1989; 1(2):153-160. PubMed ID: 11175398 [TBL] [Abstract][Full Text] [Related]
6. Effects of the 5HT(1A) agonist anxiolytic gepirone on benzodiazepine withdrawal signs in rats. Goudie AJ; Leathley MJ Behav Pharmacol; 1991 Dec; 2(6):461-469. PubMed ID: 11224088 [TBL] [Abstract][Full Text] [Related]
7. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms. Barrett JE; Witkin JM; Mansbach RS; Skolnick P; Weissman BA J Pharmacol Exp Ther; 1986 Sep; 238(3):1009-13. PubMed ID: 2875168 [TBL] [Abstract][Full Text] [Related]
8. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone. Fletcher PJ; Davies M Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586 [TBL] [Abstract][Full Text] [Related]
9. Effects of buspirone and related compounds on suppressed operant responding in rats. Sanger DJ J Pharmacol Exp Ther; 1990 Aug; 254(2):420-6. PubMed ID: 1974634 [TBL] [Abstract][Full Text] [Related]
10. Anti-conflict effect of 5-HT1A agonists in rats: a new model for evaluating anxiolytic-like activity. Hascoët M; Bourin M; Todd KG; Coüetoux du Tertre A J Psychopharmacol; 1994 Jan; 8(4):227-37. PubMed ID: 22298629 [TBL] [Abstract][Full Text] [Related]
11. The role of postsynaptic 5-HT1A receptors in the anticonflict effect of ipsapirone. Przegaliński E; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E Neuropharmacology; 1994 Sep; 33(9):1109-15. PubMed ID: 7838324 [TBL] [Abstract][Full Text] [Related]
12. Alpha 2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat. Gower AJ; Tricklebank MD Eur J Pharmacol; 1988 Oct; 155(1-2):129-37. PubMed ID: 2907485 [TBL] [Abstract][Full Text] [Related]
13. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats. Fuller RW; Perry KW J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515 [TBL] [Abstract][Full Text] [Related]
14. The central action of 1-(2-pyrimidinyl)-piperazine, an ipsapirone metabolite. Tatarczyńska E; Pawłowski L; Chojnacka-Wójcik E; Maj J Pol J Pharmacol Pharm; 1989; 41(1):51-61. PubMed ID: 2587437 [TBL] [Abstract][Full Text] [Related]
15. Gepirone and 1-(2-pyrimidinyl)-piperazine-induced reduction of aversively evoked ultrasonic vocalisation in the rat. Cullen WK; Rowan MJ Pharmacol Biochem Behav; 1994 May; 48(1):301-6. PubMed ID: 7913229 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats. Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536 [TBL] [Abstract][Full Text] [Related]
17. Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. Mansbach RS; Harrod C; Hoffmann SM; Nader MA; Lei Z; Witkin JM; Barrett JE J Pharmacol Exp Ther; 1988 Jul; 246(1):114-20. PubMed ID: 2455786 [TBL] [Abstract][Full Text] [Related]
18. [Behavioral pharmacological and electroencephalographic effects of the 5-HT1A partial agonist ipsapirone]. Yamamoto T; Shibata S; Teshima K; Inoue Y; Ushio M; Tominaga K; Ohno M; Watanabe S; Ueki S Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):41-52. PubMed ID: 1679740 [TBL] [Abstract][Full Text] [Related]
19. Anticonflict effects of acute and chronic treatments with buspirone and gepirone in rats. Yamashita S; Oishi R; Gomita Y Pharmacol Biochem Behav; 1995 Mar; 50(3):477-9. PubMed ID: 7617689 [TBL] [Abstract][Full Text] [Related]
20. Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission. McMillen BA; Scott SM; Williams HL; Sanghera MK Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):454-64. PubMed ID: 2439924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]